Current Parkinson Disease News and Events

Current Parkinson Disease News and Events, Parkinson Disease News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Genetic study of Lewy body dementia supports ties to Alzheimer's and Parkinson's diseases
In a study led by National Institutes of Health (NIH) researchers, scientists found that five genes may play a critical role in determining whether a person will suffer from Lewy body dementia, a devastating disorder that riddles the brain with clumps of abnormal protein deposits called Lewy bodies. The results also supported the disorder's ties to Parkinson's and Alzheimer diseases. (2021-02-16)

Function identified of 'mystery protein' that kills brain cells of people with Parkinson's
Scientists have made a 'vital step' towards understanding the origins of Parkinson's Disease - the fastest growing neurological condition in the world. A study published in Nature Communications today (Wednesday 10 February) presents a compelling new evidence about what a key protein called alpha-synuclein actually does in neurons in the brain. (2021-02-10)

Innovation from Vienna: Ultrasound in the treatment of brain diseases
Ultrasound is not only used as an imaging technique but targeted pulses of ultrasound can be used as a highly accurate treatment for a range of brain diseases. A review jointly written by MedUni Vienna and the University of Toronto shows that the new treatments are already on the brink of broad clinical application. (2021-02-04)

Imaging of a living brain can help clearly differentiate between two types of dementia
Scientists in Portugal and the United Kingdom were able to confirm that an imaging technique that traces neuronal dopaminergic deficiency in the brain is able to differentiate, in vivo, Alzheimer's disease from the lesser-known dementia with Lewy bodies. This could have important implications for the specific management and treatment of these conditions. (2021-02-04)

COVID-19 vaccination for patients with Parkinson's disease recommended
Patients with Parkinson's disease (PD) and healthcare professionals caring for them have expressed concerns about the COVID-19 vaccine's efficacy and safety in the specific context of PD and its symptomatic treatment. In a commentary just published in the Journal of Parkinson's Disease, a set of experts addresses these concerns from an evidence-based perspective. Their conclusion is that COVID-19 vaccination with approved vaccines should be recommended to persons with PD, unless there is a specific contraindication. (2021-02-03)

Smartwatch sensors enable remote monitoring & treatment guidance for Parkinson's patients
Scientists have developed a monitoring system based on commercial smartwatches that can detect movement issues and tremors in patients with Parkinson's disease. (2021-02-03)

Study reveals neurons responsible for rapidly stopping behaviors, actions
For the first time in humans, investigators at Cedars-Sinai have identified the neurons responsible for canceling planned behaviors or actions--a highly adaptive skill that when lost, can lead to unwanted movements. (2021-02-03)

Bile acids may play previously unknown role in Parkinson's
What does bile acid production in the digestive tract have to do with Parkinson's disease? Quite a lot, according to a sweeping new analysis published in the journal Metabolites. The findings reveal that changes in the gut microbiome -- the rich population of helpful microbes that call the digestive tract home -- may in turn alter bile acid production by favoring synthesis of toxic forms of the acids. (2021-02-02)

Prostate drug associated with lower risk of Parkinson's disease
Taking a particular type of medication to treat enlarged prostate is associated with a reduced risk of developing Parkinson's disease, according to a large observational study by researchers at the University of Iowa, and colleagues in Denmark and China. The findings, published in JAMA Neurology, suggest that terazosin, and similar medications, might have potential to prevent or delay the development of Parkinson's disease. (2021-02-01)

Our gut-brain connection
MIT researchers developed an 'organs-on-a-chip' system that replicates interactions between the brain, liver, and colon. They modeled the influence microbes living in the gut have on both healthy brain tissue and tissue samples derived from patients with Parkinson's disease. (2021-01-29)

Parkinson's disease risk and severity is tied to a channel in cells' 'recycling centers
Genetic variations associated with both increases and reductions in risk of the neurodegenerative disease alter the action of ion channels within cellular organelles called lysosomes, a new Penn study finds. (2021-01-27)

Over half of cannabis users with Parkinson's disease report clinical benefits
With medicinal cannabis now legalized in many parts of the world, there is growing interest in its use to alleviate symptoms of many illnesses including Parkinson's disease (PD). According to results of a survey of PD patients in Germany in the Journal of Parkinson's Disease, over 8% of patients with PD reported using cannabis products and more than half of those users (54%) reported a beneficial clinical effect. (2021-01-26)

Single atoms as a catalyst: Surprising effects ensue
Catalysts are getting smaller - ''single-atom'' catalysts are the logical end point of this downsizing. However, individual atoms can no longer be described using the rules developed from larger pieces of metal, so the rules used to predict which metals will be good catalysts must be revamped - this has now been achieved at TU Wien. As it turns out, single atom catalysts based on much cheaper materials might be even more effective. (2021-01-22)

Study suggests that gut fungi are not associated with Parkinson's disease
The bacterial gut microbiome is strongly associated with Parkinson's disease (PD), but no studies had previously investigated he role of fungi in the gut. In this novel study published in the Journal of Parkinson's Disease, a team of investigators at the University of British Columbia examined whether the fungal constituents of the gut microbiome are associated with PD. (2021-01-21)

New Parkinson's disease therapeutics discovered by Ben-Gurion U researchers
Dr. Claude Brodski, M.D., head of the BGU's Laboratory for Molecular Neuroscience, discovered that BMP5/7 signaling in neurons was significantly reduced in dopamine-producing brain cells, which could contribute to Parkinson's disease advancement. (2021-01-20)

Eye tests predict Parkinson's-linked cognitive decline 18 months ahead
Simple vision tests can predict which people with Parkinson's disease will develop cognitive impairment and possible dementia 18 months later, according to a new study by UCL researchers. In a related study, the researchers also found that structural and functional connections of brain regions become decoupled throughout the entire brain in people with Parkinson's disease, particularly among people with vision problems. (2021-01-19)

General health checkups may detect early signs of Parkinson's disease
A research team led by Nagoya University in Japan has found that blood pressure, the hematocrit, and serum cholesterol levels change in patients with Parkinson's disease long before the onset of motor symptoms. This finding may pave the way for early diagnosis and treatment of the disease. (2021-01-19)

Different types of neurons interact to make reaching-and-grasping tasks possible
Picking up that cup of coffee? New research from the Okinawa Institute of Science and Technology Graduate University finds that one type of neuron is necessary for the early part of the movement, another for aiming for the cup. (2021-01-19)

Study finds COVID-19 attack on brain, not lungs, triggers severe disease in mice
Georgia State University biology researchers have found that infecting the nasal passages of mice with the virus that causes COVID-19 led to a rapid, escalating attack on the brain that triggered severe illness, even after the lungs were successfully clearing themselves of the virus. (2021-01-19)

Parkinson's: Initial steps to show nerves their growth direction magnetically
One reason why nerve damage in the brain cannot regenerate easily is that the neurites do not know in which direction they should grow. A team of researchers from Ruhr-Universität Bochum (RUB), Sorbonne University Paris, and the Technische Universität Braunschweig is now working on showing them the direction using magnetic nanoparticles. (2021-01-18)

Increased risk of Parkinson's disease in patients with schizophrenia
A new study conducted at the University of Turku, Finland, shows that patients with a schizophrenia spectrum disorder have an increased risk of Parkinson's disease later in life. The increased risk may be due to alterations in the brain's dopamine system caused by dopamine receptor antagonists or neurobiological effects of schizophrenia. (2021-01-15)

Following the hops of disordered proteins could lead to future treatments of Alzheimer's disease
Researchers from the University of Cambridge, the University of Milan and Google Research have used machine learning techniques to predict how proteins, particularly those implicated in neurological diseases, completely change their shapes in a matter of microseconds. (2021-01-14)

MIND and Mediterranean diets associated with later onset of Parkinson's disease
A new study from UBC researchers suggests a strong correlation between following the MIND and Mediterranean diets and later onset of Parkinson's disease (PD). While researchers have long known of neuroprotective effects of the MIND diet for diseases like Alzheimer's and dementia, this study is the first to suggest a link between this diet and brain health for Parkinson's disease (PD). (2021-01-13)

Focused ultrasound shows promise for Parkinson's disease
A scalpel-free alternative to brain surgery has the potential to benefit people with Parkinson's disease symptoms that are much more severe on one side of the body, new research suggests. (2021-01-07)

Faulty metabolism of Parkinson's medication in the brain linked to severe side effects
Until now, the reason why the drug levodopa (L-Dopa), which reduces the motor symptoms of Parkinson's disease, declines in efficacy after a few years' use has been unknown. A side effect that then often occur is involuntary movements. A Swedish-French collaboration, led from Uppsala University, has now been able to connect the problems with defective metabolism of L-Dopa in the brain. The study is published in Science Advances. (2021-01-07)

People in rural areas less likely to receive specialty care for neurologic conditions
A new study has found that while the prevalence of neurologic conditions like dementia, stroke, Parkinson's disease and multiple sclerosis (MS) is consistent across the U.S., the distribution of neurologists is not, and people in more rural areas may be less likely to receive specialty care for certain neurologic conditions. The study, funded by the American Academy of Neurology, is published in the December 23, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology. (2020-12-23)

Cellular exclusion of mitochondria protects cells from damage
Researchers from Osaka University identified mitochondrial release out of cells as a novel mechanism by which cells turn over mitochondria and maintain cell health. The researchers found that cells deficient in the protein parkin, which is responsible for the hereditary form of Parkinson's disease (PD), showed markedly increased mitochondrial release. Further, cerebrospinal fluids of PD patients with a mutation in parkin contained elevated levels of mitochondria. This study could help develop new biomarkers and therapeutics. (2020-12-21)

Suicide risk among patients with Parkinson disease
Researchers investigated whether Parkinson disease was associated with an increased risk of suicide among a large group of patients in Taiwan. (2020-12-16)

Tomatoes offer affordable source of Parkinson's disease drug
Scientists have produced a tomato enriched in the Parkinson's disease drug L-DOPA in what could become a new, affordable source of one of the world's essential medicines. (2020-12-09)

New biomarker candidate for amyotrophic lateral sclerosis
A research team from the Centre for Protein Diagnostics (Prodi) at Ruhr University Bochum (RUB), in collaboration with scientists from Dresden Technical University, Essen University Hospital and University Hospital Göttingen, has developed a diagnostic tool for the rare neurological disease amyotrophic lateral sclerosis (ALS). The study used the patented immuno-infrared sensor to analyse folding changes of proteins in the cerebrospinal fluid (CSF) of ALS patients after specific binding. (2020-12-09)

Five-minute EEG recordings: a key to the symptoms of Parkinson's disease
Pathological changes related to the disability of Parkinson's patients can already be detected in signals from the scalp without the need to open the skull. Researchers from Leipzig University Hospital and the Max Planck Institute for Human Cognitive and Brain Sciences recently published these new findings in the journal Brain. (2020-12-09)

Reductive stress in neuroblastoma cells aggregates protein and impairs neurogenesis
Cells require a balance among oxidation-reduction reactions, or redox homeostasis. Loss of that balance to create oxidative stress is often associated with neurodegeneration. Less is known about how loss of that balance at the other end of the spectrum -- reductive stress -- may affect neurons. Now researchers show for the first time that reductive stress promotes protein aggregation in neuroblastoma cells and impairs neurogenesis. (2020-12-08)

Artificial intelligence technology helps Parkinson's patients during COVID-19 pandemic
Jessica Huber, a professor of Speech, Language, and Hearing Sciences and associate dean for research in Purdue's College of Health and Human Sciences, leads Purdue's Motor Speech Lab. Huber and her team are now doing virtual studies to evaluate speech disorders related to Parkinson's using artificial intelligence technology platforms. (2020-11-24)

Eye exam could lead to early Parkinson's disease diagnosis
A simple eye exam combined with powerful artificial intelligence (AI) machine learning technology could provide early detection of Parkinson's disease, according to research being presented at the annual meeting of the Radiological Society of North America (RSNA). (2020-11-23)

Smartphone use offers tool to treat MS, other diseases
Monitoring how patients with multiple sclerosis or other degenerative diseases use their smartphones could provide valuable information to help get them better treatment. In the journal Chaos, researchers used an app to record the keystroke dynamics of a control group and those of subjects in various stages of MS treatment. In doing so, they observed changes in the way people with MS typed that were not seen in subjects who did not have the disease. (2020-11-17)

Loneliness in Parkinson's disease may lead to worsening of symptoms
Research from UCLA scientists and colleagues from other institutions finds that people with Parkinson's disease who lack meaningful social interactions may be at an increased risk for severe symptoms related to the disease. (2020-11-17)

New technique isolates brain cells associated with Parkinson's disease
Carnegie Mellon University researchers have developed a new technique for isolating a type of brain cell associated with Parkinson's disease symptoms, enabling them to study that cell type in detail. (2020-11-16)

Brain metastases cause severe brain damage that can be inhibited by treatment
By using a specific treatment to override this activation, the researchers were able to return cerebrovascular flow to healthy levels. This improvement in blood flow around the metastases can limit the neurological deterioration associated with the progression of this disease and improve the otherwise poor life expectancy of these patients. (2020-11-12)

Innovative machine-learning approach for future diagnostic advances in Parkinson's disease
In a new study led by the Immune Systems Biology research group of the LIH Department of Infection and Immunity, researchers adopted a holistic machine-learning approach to elucidate how the interactions between neuronal mitochondria can serve as a powerful tool to distinguish nerve cells from Parkinson's patients from those belonging to healthy subjects, thereby providing new insights in the pathogenesis, diagnosis and treatment of this neurodegenerative disorder. The results were published in 'Nature Partner Journals Systems Biology and Application'. (2020-11-12)

How molecular chaperones dissolve protein aggregates linked to Parkinson's disease
In many neurodegenerative diseases, proteins clump in the brain, forming so-called amyloid fibrils. Yet there exists a cellular defence mechanism that counteracts this process and even dissolves fibrils already formed. The mechanism is based on the activity of molecular helpers, so-called chaperones of the heat shock protein 70 family. Heidelberg researchers studied how the Hsp70 system disaggregates fibrils of the Parkinson-specific protein α-synuclein in a test tube. (2020-11-11)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.